Medica RCP |Apo-Cabergoline* | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Apo-Cabergoline*

Contraindicated
Embryotoxic in animals

Contraindicated

Apo-Cabergoline* :
Type	Medicine Non Marketed
Originator	Dostinex
Agent	Promopharm
Distributor	Promopharm
Laboratory	Apotex
Responsible Party	Apotex Inc
Origin	Canada
Manufacturer	Apotex Inc
Manufacturing Type	G
Origin	Canada
ATC	G02CB03

Apo-Cabergoline* :

Oral

Apo-Cabergoline* :

G Genito-urinary system and sex hormones

G02 Other gynecologicals

G02C Other gynecologicals

G02CB Prolactine inhibitors

G02CB03 Cabergoline

Apo-Cabergoline* :

Cabergoline : 0.5mg

Apo-Cabergoline* :

Adults : Hyperprolactinemia 1mg per week

Adults : Inhibition of physiological lactation 1mg single dose

Adults : Suppression of physiological lactation 0.25mg every 12 hrs for two days

Apo-Cabergoline* :

Lactose *

Leucine

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Apo-Cabergoline* :

Revision Date : 01/11/2013

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Abdominal pain	Very Common
Aggressiveness	Not known
Alopecia	Uncommon
Angina pectoris	Not known
Asthenia	Very Common
Blackout (Blacked-out)	Uncommon
Blood creatine phosphokinase increased	Not known
Blood pressure decreased	Common
Cardiac valve disease	Very Common
Cephalea	Very Common
Chest pain	Not known
Constipation	Common
Delusion	Not known
Depression	Common
Dizziness	Very Common
Dyspepsia	Very Common
Dyspnoea (dyspnea)	Uncommon
Epigastralgia (Epigastric pain)	Rare
Epistaxis (Nasal bleeding)	Uncommon
Fatigue	Very Common
Fibrosis	Uncommon
Gastritis	Very Common
Haemoglobin decreased	Uncommon
Hallucination	Not known
Hemianopia	Uncommon
Hepatic function disorder	Not known
Hot flush	Common
Hypersensitivity reactions	Uncommon
Hypersexuality	Not known
Hypotension	Common
Leg cramps	Uncommon
Libido increased	Uncommon
Liver function test abnormal	Not known
Mastodynia	Common
Nausea	Very Common
Oedema	Uncommon
Oedema peripheral	Uncommon
Orthostatic hypotension	Common
Palpitations	Uncommon
Paraesthesia (paresthesia)	Uncommon
Pathological gambling	Not known
Pericardial effusion	Very Common
Pericarditis	Very Common
Pleural effusion	Uncommon
Pleural fibrosis	Very rare
Pleurisy (Pleuritis )	Not known
Psychotic disorders	Not known
Pulmonary fibrosis	Uncommon
Respiratory disorder	Not known
Respiratory failure	Not known
Skin Eruption	Uncommon
Somnolence	Common
Sudden onset of sleep	Not known
Syncope	Uncommon
Tremor	Not known
Vertigo	Very Common
Visual disturbance	Not known
Vomiting	Common

Medicine Authorised

Dostinex

Food & Drug Corporation

Pfizer

TAU

Parlodel²

Rahbani

Novartis

Medicine Authorised

Proctimed

Pharmamedic

Mediphar

Medicine Authorised

Proctin

Pharmamedic

Mediphar

NB : Products With Same Indication

Coming Very Soon

Different Units By MoH Code

Revision Date : 16/06/2016

Apo-Cabergoline* MoH 9665 :

Form Tablet

Package Size Box of 8

Strength 0.5mg

Storage Condition 15-30°C protect from humidity & light

NSSF ✘

Quarantine ✘

Reg. Number 56818/1

Submission date 23/04/2018

Registration Year 03/10/2018

Pending Year 13/08/2018

Pending Reason Incomplete file

Archived Date 08/04/2022

Price Comparison

Price Comparison

◼ Lebanon

◼ Country of Origin

◼ Reference Countries

◼ Other Countries

Treatment Cost

Note

Stat by year

Note

Prices are provided in Dollar ($)

You have to register to view this info

Visitors Count: 30971257

Form	Tablet
Package Size	Box of 8
Strength	0.5mg
Storage Condition	15-30°C protect from humidity & light
NSSF	✘
Quarantine	✘
Reg. Number	56818/1
Submission date	23/04/2018
Registration Year	03/10/2018
Pending Year	13/08/2018
Pending Reason	Incomplete file
Archived Date	08/04/2022